355 related articles for article (PubMed ID: 36146746)
21. A Protein Misfolding Shaking Amplification-based method for the spontaneous generation of hundreds of bona fide prions.
Eraña H; Sampedro-Torres-Quevedo C; Charco JM; Díaz-Domínguez CM; Peccati F; San-Juan-Ansoleaga M; Vidal E; Gonçalves-Anjo N; Pérez-Castro MA; González-Miranda E; Piñeiro P; Fernández-Veiga L; Galarza-Ahumada J; Fernández-Muñoz E; Perez de Nanclares G; Telling G; Geijo M; Jiménez-Osés G; Castilla J
Nat Commun; 2024 Mar; 15(1):2112. PubMed ID: 38459071
[TBL] [Abstract][Full Text] [Related]
22. Prion Diseases.
Whitechurch BC; Welton JM; Collins SJ; Lawson VA
Adv Neurobiol; 2017; 15():335-364. PubMed ID: 28674988
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
24. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
25. Selective processing and metabolism of disease-causing mutant prion proteins.
Ashok A; Hegde RS
PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
[TBL] [Abstract][Full Text] [Related]
26. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.
Hernaiz A; Toivonen JM; Bolea R; Martín-Burriel I
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293477
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of mouse prion protein in transgenic mice causes a non-transmissible spongiform encephalopathy.
Jackson GS; Linehan J; Brandner S; Asante EA; Wadsworth JDF; Collinge J
Sci Rep; 2022 Oct; 12(1):17198. PubMed ID: 36229637
[TBL] [Abstract][Full Text] [Related]
29. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
[TBL] [Abstract][Full Text] [Related]
30. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
[TBL] [Abstract][Full Text] [Related]
32. Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases.
Kabir ME; Safar JG
Prion; 2014; 8(1):111-6. PubMed ID: 24401672
[TBL] [Abstract][Full Text] [Related]
33. A systematic investigation of production of synthetic prions from recombinant prion protein.
Schmidt C; Fizet J; Properzi F; Batchelor M; Sandberg MK; Edgeworth JA; Afran L; Ho S; Badhan A; Klier S; Linehan JM; Brandner S; Hosszu LL; Tattum MH; Jat P; Clarke AR; Klöhn PC; Wadsworth JD; Jackson GS; Collinge J
Open Biol; 2015 Dec; 5(12):150165. PubMed ID: 26631378
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
35. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
37. Sequence-dependent prion protein misfolding and neurotoxicity.
Fernandez-Funez P; Zhang Y; Casas-Tinto S; Xiao X; Zou WQ; Rincon-Limas DE
J Biol Chem; 2010 Nov; 285(47):36897-908. PubMed ID: 20817727
[TBL] [Abstract][Full Text] [Related]
38. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
39. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
[TBL] [Abstract][Full Text] [Related]
40. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]